Argus On CVS Health Corp (CVS)


The Relative Volume of the company is 0.64 and Average Volume (3 months) is 7.75 million. CVS Health Corporation's revenue for the quarter was up 11.7% on a year-over-year basis. The company had a trading volume of 6,215,697 shares. The firm has a market capitalization of $84.30 billion, a price-to-earnings ratio of 16.18 and a beta of 0.85.

Now the company Insiders own 0.58% of CVS Health Corporation shares according to the proxy statements. The stock's current distance from 20-Day Simple Moving Average (SMA20) is 0.82% where SMA50 and SMA200 are 0.15% and -9.71% respectively.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Thursday, February 9th. The company reported $1.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. BP PLC raised its position in CVS Health Corporation by 17.9% in the second quarter. CVS Health Corporation (CVS) now trades with a market capitalization of $83.74 Billion.

CVS Health's support for Breathe California affiliates is part of Be The First, the company's five-year, $50 million initiative to help deliver the first tobacco-free generation and extend the company's commitment to helping people lead tobacco-free lives. Over the trailing year, the stock is underperforming the S&P 500 by 22.18, and it's gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange.

Tennis player pays off Super Bowl bet with date at Nets game
The young marketing major shot off a tweet to Bouchard asking if she'd go on a date with him if the Patriots came back to win. During the date, her rumored boyfriend Jordan Caron, shared this photo of Bouchard's Sports Illustrated debut.

CVS Health Corporation (NYSE:CVS) went up 0.94% during trading on the United States exchange when it had traded 5.62M shares.

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 2nd. Shareholders of record on Tuesday, January 24th were given a $0.50 dividend. The dividend yield based on the forward looking indicated annual dividend is 2.52%. The ex-dividend date of this dividend is Friday, January 20th. CVS Health Corporation (CVS) formally announced its most recent dividend on December 21, 2016 with a Dividend per share of $0.5.

This article was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another website, it was stolen and republished in violation of worldwide copyright and trademark law. The original version of this article can be viewed at

Other institutional investors also recently bought and sold shares of the company. Integrated Wealth Management raised its stake in CVS Health Corporation by 3.8% in the third quarter. Boston Partners now owns 4,474,349 shares of the pharmacy operator's stock valued at $398,172,000 after buying an additional 1,456,835 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new position in shares of CVS Health Corporation during the fourth quarter worth about $34,975,000. Canada Pension Plan Investment Board now owns 2,807,795 shares of the pharmacy operator's stock valued at $249,866,000 after buying an additional 1,415,802 shares during the period. CVS Health Corporation's payout ratio is presently 40.65%. Klingman & Associates LLC now owns 1,625 shares of the pharmacy operator's stock valued at $145,000 after buying an additional 350 shares during the period. Arcadia Investment Management Corp MI now owns 1,700 shares of the pharmacy operator's stock valued at $151,000 after buying an additional 95 shares during the period. Institutional investors own 81.29% of the company's stock.

Unilever Shares Soar 11% As Kraft Heinz Pursues $139 Billion Takeover
Further, Kraft Heinz noted that Unilever has declined the proposal, however it go ahead on the terms of transaction. Unilever revealed that the offer was a mix of cash and shares, valuing it at $143 billion (£115 billion).

Several equities analysts have weighed in on CVS shares. CVS Health Corp was Downgraded by Robert W. Baird on Feb 2, 2017 to Neutral, Lowers Price Target to $ 77 from a previous price target of $86.CVS Health Corp was Downgraded by Jefferies to Hold on Dec 12, 2016. Finally, Mizuho boosted their price target on shares of CVS Health Corporation from $90.00 to $111.00 and gave the company a "buy" rating in a report on Wednesday, November 9th.

Price Target plays a critical role when it comes to the Analysis of a Stock.

CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.

Trump taps Cerberus founder to head intelligence review
Describing the "Russian connection" as "nonsense", he tweeted several messages attacking intelligence agencies and media outlets. Chuck Grassley (R-Iowa), the chairman of the Senate Judiciary Committee, and the committee's top Democrat, Sen.